The acute-phase response (APR) represents a systemic reaction of the organism to multiple nonspecific inflammatory stimuli. In general, it is protective for the host, and hepatocytes are the main cells responding with alterations in the expression of a set of liver-specific proteins named the acute-phase proteins. We have previously shown that although a turpentine-induced APR is not fibrogenic per se, it enhances collagen deposition in rats treated with CCl 4 and up-regulates expression of hepatic ␣1(I) collagen and tissue inhibitor of metalloproteinases 1 (TIMP-1) messenger RNAs (mRNAs). In this report we extended our studies and showed that turpentine induced, in a time-dependent manner, expression of ␣1(I) and ␣1(IV) collagens, TIMP-1, and matrix-metalloproteinase 2 (MMP-2) mRNAs. We further showed that expression of these mRNAs occurs in hepatic stellate cells, but not in hepatocytes obtained 6 hours after the induction of an APR episode. These changes were accompanied by increased blood levels of tumor necrosis factor ␣ (TNF-␣) and interleukin 6 (IL-6) without noticeable immediate changes in the expression of their respective mRNAs in the liver. In contrast to CCl 4 -induced liver damage, turpentine alone, whether administered as a single dose or as a weekly dose for 3 weeks did not up-regulate expression of transforming growth factor ␤1 (TGF-␤1) mRNA and did not result in excess collagen deposition. Overall, these findings suggest that collagen deposition in the livers of rats with repeated APR episodes may be enhanced only when given together with a fibrogenic stimulus that activates hepatic stellate cells (HSCs) and/or up-regulates TGF-␤1 mRNA expression. (HEPATOLOGY 2001;33:597-607.)
The acute-phase response (APR) is a systemic reaction of the organism to nonspecific inflammatory stimuli that is accompanied by increased production of a cytokine cascade, which includes, among others, tumor necrosis factor ␣ (TNF-␣), interleukin 1 (IL-1), IL-6, and oncostatin M. [1] [2] [3] [4] [5] This cytokine cascade, which appears to be triggered by TNF-␣, is responsible for inducing changes in the expression of a set of hepatocyte-specific proteins named the acute phase proteins. [1] [2] [3] [4] [5] Although the APR could be beneficial for the host, and some APR cytokines play a key role in liver cell regeneration, [6] [7] [8] [9] [10] [11] [12] patients with alcohol-induced hepatitis that have several manifestations of the APR, including high blood levels of APR cytokines, develop cirrhosis. [13] [14] [15] These findings strongly suggest that in some instances, the APR and/or its cytokines may also have harmful effects and contribute to the development of liver fibrosis. 16 The molecular mechanisms that determine whether the actions exerted by the APR cytokines are beneficial (i.e., enhance hepatocyte proliferation) or harmful (i.e., induce liver fibrosis) to the patient have not been established and, therefore, need to be further investigated.
Hepatic stellate cells (HSCs) are the main producers of extracellular matrix components in normal and cirrhotic liver 17 and, thus, could play a key role in collagen gene expression induced during the APR. However, most molecular studies pertaining to the APR have been performed using either total liver and/or isolated hepatocytes. [1] [2] [3] [4] [5] [6] Thus, the role of HSCs in the APR has not been investigated, except in some studies in which cultured cells were used. 18, 19 We have previously shown that IL-6 up-regulates expression of ␣1(I) collagen messenger RNA (mRNA) in HSCs by a transcriptional and protein synthesis-dependent mechanism. 16 Moreover, we showed that the increased expression of ␣1(I) collagen mRNA that occurs in rats with an APR can be prevented by the administration of a neutralizing antibody to IL-6, but not by a nonspecific immunoglobulin. 20 In addition, others have shown that another APR cytokine, oncostatin M, induces expression of ␣1(I) collagen mRNA in cultured human HSCs. 21 Taken together, these data strongly suggest that the APR could be fibrogenic and that members of the IL-6 super family are fibrogenic both in vitro and in vivo. Indeed, the superimposition of weekly APR episodes to rats receiving CCl 4 to produce cirrhosis resulted in an enhancement of the fibrogenic process. 16 This was manifested by increased liver collagen content, as well as by enhanced expression of mRNAs encoding for ␣1(I) collagen and tissue inhibitor of metalloproteinases (TIMP-1). 16 However, in the studies described above, the temporal relationships between blood and liver levels of the APR cytokines TNF-␣ and IL-6, or between these cytokines and expression of ␣1(I) collagen mRNA was not investigated. Moreover, the possible role of HSCs in vivo in expressing other extracellular matrix components such as type IV collagen, or in proteins involved in its remodeling, i.e., matrix-metalloproteinase-2 (MMP-2), TIMP-1, or transforming growth factor ␤1 (TGF-␤1) during the APR was not analyzed. Thus, to further study the role of the APR and its cytokines in enhancing expression of extracellular matrix components by HSCs in vivo, we induced an APR in rats and determined levels of expression of ␣1(I) and ␣1(IV) collagens, TGF-␤1, MMP-2, and TIMP-1 mRNAs in freshly isolated HSCs obtained 6 hours after the induction of an APR. Our results show that a single APR episode suffices to induce in HSCs, but not in hepatocytes, a transient expression of ␣1(I) and ␣1(IV) collagen, MMP-2, and TIMP-1 mRNAs in a timedependent manner. Interestingly, up-regulation of these mRNAs follows a rapid and sharp raise in blood TNF-␣ levels and were accompanied by increased blood levels of IL-6. On the other hand, we also showed that in contrast to what happens in fibrotic liver, during the APR, expression of TGF-␤1 mRNA was not induced either in HSCs or hepatocytes.
MATERIALS AND METHODS

Animals.
Male Fisher or Sprague-Dawley rats (100 Ϯ 10 g) (Charles River Breeding Laboratories, Wilmington, MA) were used for all experiments and, except for albumin mRNA whose expression is down-regulated during the APR in Sprague-Dawley but not in Fisher rats, all findings were similar. All animals used in the present study received humane care in compliance with the guidelines of the NIH and the Animal Institute of Albert Einstein College of Medicine. Rats had free access to water and were fed ad libitum with a rodent chow diet. All animals were food deprived the night prior to performing the experiments.
Induction of Liver APR. Rats were divided into 7 groups (n ϭ 4 each). Animals in the control group did not receive any treatment and those in the 6 remaining groups received a single intradermal injection of 0.25 mL of turpentine (EM Science, Cherry Hill, NJ) per 100 g of body weight. Animals were sacrificed under ethyl ether anesthesia at 0, 3, 6, 12, 24, and 48 hours post-turpentine administration; the blood was collected by aortic puncture and transferred into tubes containing 8 mmol/L Na 2 -EDTA. For determination of serum IL-6 levels, blood was collected as described above and centrifuged at 1,000g for 15 minutes. Livers were immediately removed, frozen in liquid nitrogen and stored at Ϫ70°C.
Induction of Acute-Phase Episodes in CCl 4 -Treated Rats. Rats were divided into 4 groups (n ϭ 4 each). The control group did not receive any treatment. The acute-phase group received once a week an intradermal injection of 0.25 mL of turpentine per 100 g of body weight. Liver fibrosis was induced in the third group by intraperitoneal injection 3 times a week of 0.15 mL CCl 4 (Fisher Scientific, Pittsburgh, PA) in mineral oil (Sigma, St. Louis, MO) (1:5) as previously described. 16 The fourth group received the combined treatment of CCl 4 to produce fibrosis and turpentine to induce acute phase episodes at the same doses as described above. Rats were sacrificed under ethyl ether anesthesia after 9 doses of CCl 4 and/or 3 APR episodes. All specimens were obtained 7 days after the last CCl 4 dose and/or 72 hours after the last turpentine administration. Blood was obtained as described above, and livers were removed, frozen in liquid nitrogen, and stored at Ϫ70°C.
Isolation of HSCs and Hepatocytes. Three control and 3 turpentinetreated rats were used for these experiments. Six hours after the administration of turpentine, hepatocytes and HSCs were isolated by liver perfusion with bacterial collagenase according to previously published protocols. 18, 19 Cell viability was assessed by the trypan blue exclusion test and was found to be 98%. Purity of each fraction was determined as described previously and shown to be 95% for hepatocytes and 92% for HSCs.
Northern Analysis. Total RNA was extracted from either 50 mg of liver or from freshly isolated cells. 22 Ten micrograms of RNA from liver or 3 g from freshly isolated cells were electrophoresed under denaturing conditions in 1% agarose/formaldehyde gels and transferred onto Gene-screen nylon membranes (Dupont, Boston, MA). The following 32 P-labeled complementary DNA (cDNA) probes were used: rat ␣1(I) 23 and ␣1(IV) collagens, 24 fibronectin, 25 MMP-13, 26 and MMP-2, 27 fibrinogen, 28 albumin, 29 TIMP-1, 30 and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (ATCC, Rockville, MD). All blots were washed under stringent conditions, except when hybridized to human GAPDH cDNA when washes were performed under nonstringent conditions. 31 Quantitative analysis of signals generated by X-ray film exposure was performed by photodensitometry. Values were corrected using the GAPDH signal as a control and refer to mean Ϯ SE (n ϭ 4).
Plasma levels of TNF-␣ were measured using a rat TNF-␣ ultra sensitive cytoscreen US ELISA Kit (Biosource, Camarillo, CA) according to the instructions provided by the manufacturer. Values are expressed as pg/mL of plasma and refer to mean Ϯ SE (n ϭ 4).
Serum Levels of IL-6. IL-6 levels were determined measuring the IL-6 -dependent proliferation of the B9 murine plasmacytoma cell line, as previously described [32] [33] [34] using serial dilutions of serum. One unit of activity is defined as the dilution that gives half-maximal B9 cell growth in 72 hours and corresponds to approximately 2 ng/L rhIL-6.
Reverse Transcription-Polymerase Chain Reaction. First-strand cDNA was synthesized using 2 g of total RNA, 1 L of placental RNase inhibitor (Ambion, Austin, TX), 1 mL of reverse transcription-polymerase chain reaction (RT-PCR) buffer (Roche Diagnostics, Indianapolis, IN), 2.5 mmol/L dNTPs (Roche), 500 ng of random primers, and 1 U of Moloney Murine leukemia virus reverse transcriptase (Roche) in a final volume of 20 L. The reaction was carried out for 60 minutes at 42°C.
The PCR reaction was performed as previously described 35 using the following primer pairs: 5Ј CGA GTG ACA AGC CCG TAG CC 3Ј (TNF-␣ forward); 5Ј GGA TGA ACA CGC CAG TCG CC 3Ј (TNF-␣ reverse); 5ЈATG GAT GAC GAT ATC GCT 3Ј (␤ actin forward); 5Ј TGG ACT GTC TGA TGG AGTA 3Ј (␤ actin reverse). For TGF-␤1 and 18S, the cDNA was amplified using commercially available sets of primers (Ambion). Each PCR reaction contained 0.4 mol/L of specific primer pairs, 200 mol/L dNTPs, 1 U of platinum Taq high fidelity polymerase (Gibco, Grand Island, NY), 1 mL high fidelity PCR buffer (Gibco), and 2 Ci of radiolabeled dCTP (Amersham, Piscataway, NJ) in a total volume of 50 L. Amplification reactions were cycled as follows: initial denaturation at 95°C for 5 minutes; 30 cycles: 95°C for 1 minute, 60°C for 1 minute, and 72°C for 1 minute; final extension was carried out at 72°C for 5 minutes. The PCR products were resolved on a 6% nondenaturating acrylamide gel, dried, and quantified using a Phosphorimager and the Image Quant software (Molecular Dynamics, Sunnyvale, CA). Under these experimental conditions, results obtained were within the linear range. 35 Statistical Analysis. Statistical analysis was performed with the Student's t test.
RESULTS
To induce an APR and avoid producing overt liver injury we used half the recommended dose of turpentine. 36, 37 There-fore, we first determined whether the rats had indeed an APR and measured blood levels of TNF-␣ and IL-6 and liver steady-state levels of TNF-␣, IL-6, and fibrinogen mRNAs. As illustrated in Fig. 1A , within the first 5 minutes after turpentine administration to rats, there was a sharp increment in plasma TNF-␣ levels from 13.9 to 53.7 pg/mL (P Ͻ .001). This increase was transient, since TNF-␣ values decreased to 24.5 pg/mL by 90 minutes (P Ͻ .005) and reached normal values by 24 hours. Semi-quantitative RT-PCR studies using total liver RNA revealed a significant increase in TNF-␣ mRNA expression by 12 hours (3.7-fold above controls) (P Ͻ .001) (Fig. 1B) . However, mRNA levels did not correlate with blood cytokine concentrations (Fig. 1A) . Although TNF-␣ mRNA values decreased to 2.5-fold above control levels by 24 hours (P Ͻ .05), they remained elevated by 48 hours (3.2-fold; P Ͻ .05). As shown in Fig. 1C , serum IL-6 levels, as determined by the IL-6 -dependent proliferation of the B9 murine plasmocytoma cell line, in control untreated animals were undetectable. In contrast with these findings, there was a significant increase in IL-6 levels in serum obtained from rats treated with turpentine for 6 hours (4.5 ng/L ϫ 10 3 ), the same time point selected to analyze mRNA expression in HSCs isolated from turpentine-treated rats (see below) (Fig. 1C) . These levels of serum IL-6 are in agreement with previous publications in which turpentine was used to induce an APR in rats. 38 IL-6 mRNA levels in total liver, analyzed by PCR studies were very low and similar in all samples analyzed (data not shown). Increased levels of blood TNF-␣ and IL-6 were accompanied by up-regulation of fibrinogen mRNA, a bona fide positive APR mRNA. As shown in Fig. 2A , fibrinogen mRNA reached its maximum value at 12 hours (9.3-fold above control; P Ͻ .001) and decreased thereafter to 3-fold above controls by 48 hours (P Ͻ .005).
Once we established that the rats were indeed in an APR, we analyzed expression of several genes related to extracellular matrix formation. As shown in Fig. 2B , ␣1(I) collagen mRNA expression was induced 7.6-fold after 6 hours and remained 3.3-fold above control values at 48 hours (P Ͻ .001). Changes in expression of ␣1(I) collagen were not accompanied by a detectable increase in either MMP-13 or TIMP-1 mRNAs (data not shown). Fibronectin mRNA levels showed the same pattern of induction as fibrinogen mRNA with an 11.2-fold increase above controls at 12 hours (P Ͻ .001) (Fig. 2C) .
Type IV collagen is a key component of the space of Disse. Since collagenization of this space and formation of a basement membrane are important events in liver fibrogenesis, we investigated whether ␣1(IV) collagen and MMP-2 mRNA expression was also induced during the APR. Since ␣1(IV) collagen and MMP-2 mRNA expression was not detected in the control group, results were expressed in arbitrary units. As shown in Fig. 3A , rats with an APR episode showed a significant induction of ␣1(IV) collagen mRNA with maximal values at 12 hours (P Ͻ .001). Although levels of expression of this mRNA decreased thereafter, they were still detectable at 48
Plasma levels of TNF-␣ in rats with an APR episode. Plasma TNF-␣ concentration was measured by ELISA at 0, 5 minutes, and 1.5, 3, 6, 12, 24, and 48 hours after the intradermal injection of a single dose of turpentine. A sharp, but transient increase in plasma TNF-␣ levels was observed within the first 5 minutes, decreasing at 90 minutes and returning to normal values by 24 hours. Results are expressed as pg/mL, and refer to mean Ϯ SE (n ϭ 4). *P Ͻ .05; **P Ͻ .005; ***P Ͻ .001 when compared to values at 0 hours. (B) TNF-␣ semiquantitative RT-PCR of RNA from rats with an APR episode. Liver TNF-␣ expression showed a maximum value of 3.7-fold above control at 12 hours and remained elevated above control values by 48 hours. All values were corrected for the ␤-actin signal as described in the Materials and Methods. Results are expressed as fold increase above control, and refer to mean Ϯ SE (n ϭ 4). *P Ͻ .05; **P Ͻ .005; ***P Ͻ .001 when compared with the control group. (C) Serum levels of IL-6 in rats with APR. Serum IL-6 concentration was determined 6 hours after the injection of turpentine. Although no levels of IL-6 were detected in control rats, 4.5 ng/L ϫ 10 3 were found 6 hours after turpentine administration (n ϭ 4). All values were corrected for differences in loading using the GAPDH signal as described in the Materials and Methods. Results are expressed as fold increase above control for fibrinogen and fibronectin with control assigned a value of 1 and in arbitrary units for ␣1(I) collagen and refer to mean Ϯ SE. *P Ͻ .05; **P Ͻ .005; ***P Ͻ .001.
hours post-turpentine administration (P Ͻ .005). As shown in Fig. 3B , a parallel elevation in the expression of MMP-2 mRNA, a gelatinase involved in type IV collagen degradation, was observed after 3 hours (P Ͻ .005). Its expression was also transient and significantly decreased to control levels by 48 hours. No detectable levels of TIMP-1 mRNA were found in samples of total liver RNA at all time points investigated (data not shown).
The results described above suggest that expression of ␣1(I) and ␣1(IV) collagens, fibronectin, and MMP-2 mRNAs increase in livers of rats with an APR. However, these experiments did not reveal which liver cell type is responsible for the induction of such mRNAs. Hence, to study the role of hepatocytes and HSCs in the expression of these mRNAs, we isolated total RNA from hepatocytes and HSCs obtained from rats treated with or without turpentine for 6 hours. This time point was selected because, as shown in Figs. 2 and 3 , steadystate levels of the mRNAs investigated were already elevated several fold above control values. As shown in Fig. 4A and B, fibrinogen mRNA was detected in hepatocytes of control rats and its expression was significantly increased after turpentine administration. As expected, fibrinogen mRNA was not expressed in HSCs from control rats. Surprisingly, however, low but nonetheless measurable levels of fibrinogen mRNA were detected in HSCs obtained from turpentine-treated rats. Although we have no explanation for these findings, it is possible that the HSC fraction was contaminated with small hepatocytes that do not sediment at low speed centrifugation and are resistant to pronase digestion.
As illustrated in Fig. 4A , no signal for ␣1(I) collagen, MMP-2, or TIMP-1 mRNAs was detected in hepatocytes from control or turpentine-treated rats. In contrast to these findings, HSCs expressed variable levels of ␣1(I) and ␣1(IV) collagen mRNAs, and these were significantly up-regulated in cells obtained from livers of rats with an APR episode ( Fig. 4C  and D) . On the other hand, although a weak signal for ␣1(IV) collagen mRNA was detected in hepatocytes from control rats and its expression was slightly increased after turpentine ad- ministration, the differences observed were marginal and were not statistically significant (Fig. 4D) . No signal for MMP-2 or TGF-␤1 mRNA was detected in HSCs from control rats. However, while the former mRNA was significantly upregulated in HSCs from turpentine-treated rats (Fig. 4E) , the latter remained undetectable (data not shown). Interestingly, although TIMP-1 mRNA levels were not detectable in total RNA from control or turpentine-treated rats (data not shown), very low levels were detected in RNA obtained from control HSCs. Moreover, this mRNA was significantly upregulated in HSCs from turpentine-treated rats (Fig. 4F) .
After establishing the changes in blood TNF-␣ and serum IL-6 and liver mRNA levels, expression of ␣1(I) and ␣1(IV) collagens, MMP-2, TIMP-1, and TGF-␤1 mRNAs induced by a single APR episode, we analyzed these parameters in rats treated once a week for 3 weeks with turpentine, rats treated with CCl 4 3 times a week for 3 weeks to produce liver fibrosis, and in rats receiving the combined treatment. Based on our findings and those of others, 39, 40 namely the transient expression of the various mRNAs investigated after turpentine or acute CCl 4 administration, in the chronic experiments rats were sacrificed 7 days after the last turpentine administration and/or 3 days after the final dose of CCl 4 . Accordingly, mRNA values reflect alterations induced by chronic treatment and not those induced by the last dose of turpentine or CCl 4 . As shown in Fig. 5 , plasma TNF-␣ levels increased from 13.8 Ϯ 0.63 pg/mL in untreated control animals to 37.1 Ϯ 2.23 pg/mL in those receiving turpentine (P Ͻ .05). It is noteworthy to mention that this value, which was obtained 7 days postturpentine administration, is significantly higher (ϳ2-to 3-fold) than that found by 48 hours in rats receiving a single APR episode, thus suggesting a sustained effect in animals receiving multiple APR stimuli. TNF-␣ values in CCl 4 -treated rats were normal (14.1 Ϯ 0.84 pg/mL) and were similar to control values. The combined treatment of CCl 4 to produce cirrhosis plus a weekly induction of APR episodes increased TNF-␣ plasma levels to 55.7 Ϯ 3.1 pg/mL, a value significantly higher than that found in rats with APR (P Ͻ .005). On the other hand, IL-6 mRNA levels, determined by RT-PCR revealed that this mRNA was increased in all the experimental groups. However, differences among them were not significant (Fig. 5B) .
The data regarding the expression of extracellular matrixrelated mRNAs confirmed our previous observations. 16 As shown in Fig. 6A and B, we confirmed that ␣1(I) collagen and TIMP-1 mRNAs are up-regulated in rats treated for 3 weeks with CCl 4 , and that these mRNAs are further up-regulated in rats receiving turpentine plus CCl 4 (P Ͻ .001; P Ͻ .001, respectively). In addition, we showed that expression of ␣1(IV) collagen and MMP-2 mRNAs is also up-regulated in CCl 4 -treated rats and that their levels are significantly higher in rats receiving the combined treatment (P Ͻ .001, P Ͻ .001, respectively) (Fig. 6C and D) .
To investigate whether TGF-␤1 plays a role, if any, in the APR-mediated up-regulation of the collagen genes investigated, TGF-␤1 mRNA levels were measured in livers of rats chronically treated with turpentine, CCl 4 , and turpentine plus CCl 4 . As shown in Fig. 7 , TGF-␤1 mRNA was only up-regulated in livers of rats receiving CCl 4 alone or in combination with turpentine (P Ͻ .001). However, TGF-␤1 mRNA levels were not statistically different in livers receiving the combined treatment as compared with those treated only with CCl 4 .
DISCUSSION
TNF-␣, IL-6, and IL-1 are 3 of the main cytokines involved in the APR, 1-5 which also play a key role in liver regeneration, [6] [7] [8] [9] [10] [11] [12] and influence the expression and turnover of various extracellular matrix components. 16, 20, 21, 41 It has been postulated that the APR, its cytokines and/or the proteins whose expression is modified by them, play an important role in maintaining homeostasis. 42, 43 However, recent evidence suggests that in some instances, the APR and/or its cytokines may enhance and/or accelerate pathologic processes. 16, [44] [45] [46] [47] Indeed, patients with alcohol-induced hepatitis have clinical FIG. 5 . Expression of TNF-␣ in CCl 4 -treated rats with and without repeated APR episodes. Rats were treated with either turpentine once a week for 3 weeks, an intraperitoneal CCl 4 injection 3 times a week for 3 weeks, or both. Blood TNF-␣ values, determined by ELISA, increased from 13.8 Ϯ 0.63 pg/mL in the control group to 37.1 Ϯ 2.23 pg/mL in those receiving turpentine (P Ͻ .05). Cytokine blood levels in CCl 4 -treated rats remained unchanged, whereas in those receiving the combined treatment, TNF-␣ levels increased to 55.7 Ϯ 3.1 pg/mL. Results are expressed in pg/mL and refer to mean Ϯ SE (n ϭ 4). *P Ͻ .05; **P Ͻ .005. (B) IL-6 mRNA values, as determined by RT-PCR, show that although there is increased expression of this mRNA in livers of rats treated with CCl 4 and CCl 4 plus turpentine, there were no significant differences among these 2 groups.
manifestations of the APR and their blood APR cytokine levels are increased. [13] [14] [15] Moreover, although not all alcoholic patients develop cirrhosis, a relatively large percent of those with alcohol-induced hepatitis develop it. [13] [14] [15] In a rat model of alcohol-induced liver fibrosis, levels of APR cytokines increase prior to the development of overt liver fibrosis. 48 In addition, we have previously shown that the superimposition of weekly APR episodes to rats receiving chronic treatment with CCl 4 accelerates the deposition of collagen and, thus, enhances the development of liver fibrosis. 16 Because rats receiving weekly injections of turpentine for 3 weeks did not develop a sustained elevation in ␣1(I) collagen and TIMP-1 mRNAs and there was no increase in total liver collagen, we concluded that the APR, per se, is not fibrogenic. 16 Conversely, because those rats receiving the combined CCl 4 /turpentine had more liver fibrosis, contained more liver collagen, and expressed higher levels of ␣1(I) collagen and TIMP-1 mRNAs than those treated with CCl 4 alone, we proposed that the APR enhances fibrosis in rats only when they are undergoing liver injury. 16 Because HSCs are already activated and produce more collagen when isolated from CCl 4 -treated rats, and these cells respond to IL-6 administration with a significant elevation in ␣1(I) collagen and TGF-␤1 mRNAs, 20 we speculated that the APR could be fibrogenic only when HSCs are already activated.
Based on the aforementioned data, the aim of the present study was to establish the contribution of HSCs to the APR in general, and to start elucidating some of the mechanisms whereby these cells increase their expression of extracellular matrix components during the APR. Thus, based on the known fact that TNF-␣ is one of the APR cytokines that upregulates expression of IL-6, 1-3 and IL-6 is one of the cytokines FIG. 6 . Expression of ␣1(I) collagen, ␣1(IV) collagen, MMP-2, and TIMP-1 mRNA in CCl 4 -treated rats with and without repeated APR episodes. Rats were treated with either turpentine once a week for 3 weeks, or an intraperitoneal CCl 4 injection 3 times a week for 3 weeks, or both, and total RNA was isolated and analyzed by Northern blot. ␣1(I) collagen (A) and TIMP-1 (B) mRNAs are up-regulated in rats treated for 3 weeks with CCl 4 and these mRNAs are further up-regulated in rats receiving turpentine plus CCl 4 . The expression of ␣1(IV) collagen (C) and MMP-2 (D) mRNAs is also upregulated in CCl 4 -treated rats and their levels are significantly higher in rats receiving the combined treatment (P Ͻ .001). All values were corrected for loading differences using GAPDH cDNA as a control. Results are expressed as arbitrary units and are means Ϯ SE of triplicate experiments (***P Ͻ .001).
that induces ␣1(I) collagen gene expression in cultured rat HSCs, 20 we first analyzed the temporal expression of TNF-␣ and IL-6 in blood and livers of rats with an APR episode. In addition, we performed experiments to investigate the contribution of HSCs to the expression of genes encoding some extracellular matrix components during the APR. Finally, because we have previously shown that TGF-␤1 is induced by IL-6 only in HSCs derived from cirrhotic livers, we determined whether expression of this mRNA was elevated in livers of turpentine-treated rats, and whether it played a role in up-regulating ␣1(I) and ␣1(IV) collagen, MMP-2, and TIMP-1 mRNAs in livers of turpentine-treated rats.
Our studies revealed that rats treated acutely with turpentine were indeed in acute phase as manifested by the increased expression of fibrinogen mRNA in total RNA extracted from livers, as well as from hepatocytes. Moreover, because blood TNF-␣ levels increased sharply prior to detecting a significant increase in the expression of its messenger in the liver, the data suggested the possibility that this cytokine may be released from a preexisting pool. Indeed, it has been previously shown that a precursor form of TNF-␣ is present in cells and that the active cytokine can be released by limited proteolysis by a specific TNF-␣-converting enzyme named TACE. 49 However, the cells that express this cytokine and/or TACE were not analyzed, and thus this needs to be further investigated. On the other hand, our data clearly showed that there is an increase in serum IL-6 levels in rats treated with turpentine for 6 hours. Although the changes in IL-6 were relatively modest, they were, nonetheless, significant and were only detected in turpentine-treated rats and not in controls. These findings are in agreement with data in the literature showing that in contrast to endotoxin, turpentine induces a more modest cytokine response. 38 However, in both cases, namely turpentine or endotoxin administration, cytokine levels are sufficient to induce the typical changes observed in the APR.
With regard to the role of HSCs in the APR, we showed that a single injection of turpentine sufficed to induce expression of ␣1(I) and ␣1(IV) collagens, TIMP-1, and MMP-2 mRNAs by HSCs isolated 6 hours after turpentine administration. Because these cells were isolated directly from rats treated with turpentine and RNA extracted immediately upon isolation, the steady-state levels of ␣1(I) and ␣1(IV) collagens, MMP-2, TIMP-1, and TGF-␤1 mRNAs found reflect the level of their expression in vivo. These findings show that HSCs are important mediators of the APR and contribute, together with hepatocytes, to the overall response of the host to nonspecific inflammatory stimuli.
In response to a single APR stimulus, HSCs express increased levels of mRNAs encoding extracellular matrix components that are found elevated in cirrhotic livers. Indeed, type I collagen is one of the main components of scar tissue and type IV collagen is a key protein involved in the capillarization of the space of Disse. 50 Nonetheless, no expression of TGF-␤1 mRNA was detected and no overt deposition of collagen was found as determined by histologic and/or histochemical analysis of the liver (data not shown). These data confirmed our previous findings suggesting that the APR by itself is not fibrogenic and that additional events, which may occur after CCl 4 administration, are required for the APR to enhance the fibrogenic process. Because TGF-␤1 is the classic fibrogenic cytokine and its expression is up-regulated in livers of cirrhotic animals and patients, we further investigated this cytokine. 51, 52 Thus, we analyzed expression of TGF-␤1 mRNA in total liver RNA from rats treated with a single dose of turpentine to induce the APR, in rats treated for 3 weeks with CCl 4 to induce liver fibrosis, and in rats treated with CCl 4 for 3 weeks plus a weekly induction of APR episodes. As shown in this report, a single dose of turpentine up-regulated expression of ␣1(I) and ␣1(IV) collagens, TIMP-1, and MMP-2 in HSCs, while no TGF-␤1 mRNA was detected. These findings suggest that TGF-␤1 does not play a role in the up-regulation of the expression of this mRNA in turpentinetreated rats. However, further studies measuring TGF-␤1 protein levels may be required to confirm this hypothesis.
On the other hand, our result showing increased production of IL-6, together with our previous findings showing that a neutralizing antibody to IL-6 prevented ␣1(I) collagen mRNA up-regulation induced by turpentine, suggest that al- terations in collagen gene expression in HSCs observed after turpentine administration are due to the production of IL-6. However, we cannot rule that other cytokines, including oncostatin M may play a role in this process. 21 In the chronic studies we confirmed our previous observations showing that the combined treatment of CCl 4 plus turpentine is more fibrogenic that CCl 4 treatment alone. 16 In addition we further showed that the acute or chronic treatment with turpentine results in up-regulation of ␣1(I) collagen and MMP-2 mRNAs. While the former is involved in basement membrane formation, the latter plays a role in its remodeling. 53 In this chronic model, levels of expression of TGF-␤1 mRNA are elevated only in rats receiving CCl 4 or the combined treatment of CCl 4 plus a weekly APR episode, but not in control animals receiving only a weekly induction of an APR episode. Interestingly, although TGF-␤1 mRNA levels were higher in animals with the combined treatment, they were not significantly different from values obtained with rats treated only with CCl 4 . Thus, although the data support the notion that the APR enhances fibrogenesis in CCl 4 -treated rats, the molecular events whereby this occurs remain to be fully elucidated. Because HSCs in rats treated with CCl 4 are already activated in vivo, it is conceivable to suggest that the fibrogenic actions of the APR take place only in livers in which HSCs are activated and committed to produce collagen. Consequently, it could be speculated that in patients with chronic liver disease, in which HSCs are already activated and/or already have various degrees of liver fibrosis, repeated APR episodes occurring during acute liver injury (i.e., alcohol-induced hepatitis) or secondary to nonspecific inflammatory events, may exacerbate liver fibrogenesis. This possibility is currently being explored in our laboratory.
